Cibc World Market Inc. Novo Cure LTD Transaction History

Cibc World Market Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $1.3 Million - $1.99 Million	-10,439 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$112.16 - $174.14 $614,748 - $954,461	5,481 Added 110.55%	10,439 $1.81 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $287,811 - $551,874	4,958 New	4,958 $552,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.